Reversal of rocuronium induced neuromuscular blockade using sugammadex in a patient with eclampsia treated by magnesium intraoperatively

Reversal of rocuronium induced neuromuscular blockade using sugammadex in a patient with eclampsia treated by magnesium intraoperatively

Bibliographic Details
Main Authors:	Sejin Song, Byung Hoon Yoo, Kye-Min Kim, Sangseok Lee
Format:	Article
Language:	English
Published:	Korean Society of Anesthesiologists 2014-12-01
Series:	Korean Journal of Anesthesiology
Online Access:	http://ekja.org/upload/pdf/kjae-67-S102.pdf

Similar Items

Sugammadex ED90 dose to reverse the rocuronium neuromuscular blockade in obese patients
by: MAURO PRADO DA SILVA, et al.

Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
by: Tiffany Woo, et al.
Published: (2013-12-01)

Negative Pressure Pulmonary Edema after Reversing Rocuronium-Induced Neuromuscular Blockade by Sugammadex
by: Manzo Suzuki, et al.
Published: (2014-01-01)

Reversal with sugammadex for rocuronium-induced deep neuromuscular block after pretreatment of magnesium sulfate in rabbits
by: Woon Seok Kang, et al.
Published: (2017-04-01)

The effect of magnesium on the reversal of rocuronium-induced neuromuscular block with sugammadex: an ex vivo laboratory study
by: Ákos I. Fábián, et al.
Published: (2019-05-01)

The safety and necessity of Sugammadex in neuromuscular blockade reversal
by: Liu, Yitao
Published: (2015)

A Meta-Analysis on the Effect of Dexamethasone on the Sugammadex Reversal of Rocuronium-Induced Neuromuscular Block
by: Chang-Hoon Koo, et al.
Published: (2020-04-01)

Relationship between first-twitch depression and train-of-four ratio during sugammadex reversal of rocuronium-induced neuromuscular blockade
by: Kyo Sang Kim, et al.
Published: (2016-06-01)

Effect of ulinastatin on the rocuronium-induced neuromuscular blockade
by: Min Soo Kim, et al.
Published: (2012-03-01)

Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy
by: Marie T. Aouad, et al.
Published: (2017-04-01)

Sensitivity to Rocuronium-Induced Neuromuscular Block and Reversibility with Sugammadex in a Patient with Myotonic Dystrophy
by: Akihiro Kashiwai, et al.
Published: (2012-01-01)

Effects of rocuronium, sugammadex and rocuronium-sugammadex complex on coagulation in rats
by: Ismar Lima Cavalcanti, et al.
Published: (2020-11-01)

Profile of sugammadex for reversal of neuromuscular blockade in the elderly: current perspectives
by: Carron M, et al.
Published: (2017-12-01)

The effect of high concentration of magnesium with ropivacaine, gentamicin, rocuronium, and their combination on neuromuscular blockade
by: Won Ji Rhee, et al.
Published: (2015-02-01)

The effect of long-term oral dantrolene on the neuromuscular action of rocuronium: a case report
by: Jinwoo Jeon, et al.
Published: (2014-02-01)

The use of 3 sugammadex out of 5 reversal of during recovery of rocuronium-induced neuromuscular blockade in a patient with post-tonsillectomy hemorrhage: a case report
by: Hee-Jong Lee, et al.
Published: (2014-07-01)

Retrospective Study of the Restoration of Neuromuscular Blockage with Sugammadex in Newborns Who Used Rocuronium
by: Hacer Şebnem Türk, et al.
Published: (2019-07-01)

Sugammadex: A neuromuscular blockade agent encapsulator
by: Victoria Yepes Hurtado
Published: (2017-07-01)

Half-dose sugammadex with neostigmine versus full-dose sugammadex for reversal of rocuronium in laparoscopic bariatric surgery
by: Mohamed A. Ghanem, et al.
Published: (2020-07-01)

Use of rocuronium and sugammadex under neuromuscular transmission monitoring in a patient with multiple sclerosis
by: Chryssoula Staikou, et al.
Published: (2017-01-01)

Analysis of incidence of residue neuromuscular blockade for rocuronium and cisatracurium
by: Qing-Long Dong
Published: (2020-11-01)

Economic analysis of sugammadex versus neostigmine for reversal of neuromuscular blockade for laparoscopic surgery in China
by: Maodong Ren, et al.
Published: (2020-11-01)

Sugammadex to reverse neuromuscular blockade in a child with a past history of cardiac transplantation
by: Karen Miller, et al.
Published: (2017-01-01)

Sugammadex to reverse neuromuscular blockade and provide optimal conditions for motor-evoked potential monitoring
by: Mehdi Trifa, et al.
Published: (2017-01-01)

Repeat dosing of rocuronium-sugammadex: unpredictable
by: Yoon-Hee Kim
Published: (2014-07-01)

Rocuronium-Sugammadex in Anesthesia for Electroconvulsive Therapy
by: Nilay Tas, et al.
Published: (2016-03-01)

Effects of different sugammadex doses on the train of four ratio recovery progression during rocuronium induced neuromuscular blockade in the rat phrenic nerve hemidiaphragm
by: Yong Beom Kim, et al.
Published: (2020-06-01)

Anaphylaxis induced by sugammadex and sugammadex-rocuronium complex -a case report-
by: Shu Chung Choi, et al.
Published: (2020-08-01)

At therapeutic concentration bupivacaine causes neuromuscular blockade and enhances rocuronium-induced blockade
by: Ji Hyeon Lee, et al.
Published: (2012-05-01)

Economic impact of improving patient safety using Sugammadex for routine reversal of neuromuscular blockade in Spain
by: J. Martinez-Ubieto, et al.
Published: (2021-02-01)

The synergistic effect of gentamicin and clindamycin on rocuronium-induced neuromuscular blockade
by: Ji Hyeon Lee, et al.
Published: (2013-02-01)

Rocuronium reversal: sugammadex versus neostigmine in asthmatic patients undergoing open cholecystectomy
by: Niven Gerges Fahmy, et al.
Published: (2019-12-01)

Sugammadex versus two doses of neostigmine for reversal of rocuronium in gastric sleeve surgery
by: Abdulhamid Alsaeed, et al.
Published: (2017-01-01)

Sugammadex vs. neostigmine/glycopyrrolate for routine reversal of rocuronium block in adult patients
by: Hurford, William E.
Published: (2019)

Effects of sevoflurane and adenosine receptor antagonist on the sugammadex‐induced recovery from rocuronium‐induced neuromuscular blockade in rodent phrenic nerve–hemidiaphragm tissue specimens
by: Yong Beom Kim, et al.
Published: (2021-08-01)

The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade
by: Soon Ho Cheong, et al.
Published: (2015-12-01)

The efficacy and safety of sugammadex for reversing postoperative residual neuromuscular blockade in pediatric patients: A systematic review
by: Guangyu Liu, et al.
Published: (2017-07-01)

Cardiac arrest after administration of sugammadex as neuromuscular blockade reversal agent and full recovery from anesthesia
by: Evangelia Samara, et al.
Published: (2020-01-01)

Effects of dexamethasone and hydrocortisone on rocuroniuminduced neuromuscular blockade and reversal by sugammadex in phrenic nerve-hemidiaphragm rat model
by: Heyran Choi, et al.
Published: (2019-08-01)

Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome
by: Thomas Ledowski, et al.
Published: (2013-01-01)